Therapeutic efficacy of nanoparticles and routes of administration

다국어 초록 (Multilingual Abstract)

In modern-day medicine, nanotechnology and nanoparticles are some of the indispensable tools in disease monitoring and therapy. The term “nanomaterials” describes materials with nanoscale dimensions (< 100 nm) and are broadly classified into natural and synthetic nanomaterials. However, “engineered” nanomaterials have received significant attention due to their versatility. Although enormous strides have been made in research and development in the field of nanotechnology, it is often confusing for beginners to make an informed choice regarding the nanocarrier system and its potential applications. Hence, in this review, we have endeavored to briefly explain the most commonly used nanomaterials, their core properties and how surface functionalization would facilitate competent delivery of drugs or therapeutic molecules. Similarly, the suitability of carbon-based nanomaterials like CNT and QD has been discussed for targeted drug delivery and siRNA therapy. One of the biggest challenges in the formulation of drug delivery systems is fulfilling targeted/specific drug delivery, controlling drug release and preventing opsonization. Thus, a different mechanism of drug targeting, the role of suitable drug-laden nanocarrier fabrication and methods to augment drug solubility and bioavailability are discussed. Additionally, different routes of nanocarrier administration are discussed to provide greater understanding of the biological and other barriers and their impact on drug transport. The overall aim of this article is to facilitate straightforward perception of nanocarrier design, routes of various nanoparticle administration and the challenges associated with each drug delivery method.

참고문헌 (Reference)

• 1 Oh Y, "pH and NIR-light-responsive magnetic iron oxide nanoparticles for mitochondria-mediated apoptotic cell death induced by chemo-photothermal therapy" 531 (531): 1-3, 2017
• 2 Fadel M, "Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice" 25 (25): 283-292, 2010
• 3 Gnach A, "Upconverting nanoparticles : assessing the toxicity" 44 (44): 1561-1584, 2015
• 4 Geiser M, "Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells" 113 (113): 1555-, 2005
• 5 Nedyalkov N, "Tuning optical properties of noble metal nanoparticle-composed glasses by laser radiation" 463 : 968-975, 2019
• 6 Maeda H, "Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review" 65 (65): 271-284, 2000
• 7 Torchilin V, "Tumor delivery of macromolecular drugs based on the EPR effect" 63 (63): 131-135, 2011
• 8 Prausnitz MR, "Transdermal drug delivery" 26 (26): 1261-1268, 2008
• 9 Jain S, "Toxicity issues related to biomedical applications of carbon nanotubes" 3 (3): 2-, 2012
• 10 Canelas DA, "Top-down particle fabrication : control of size and shape for diagnostic imaging and drug delivery" 1 (1): 391-404, 2009
• 11 Dalwadi C, "Thermosensitive nanohydrogel of 5-fluorouracil for head and neck cancer : preparation, characterization and cytotoxicity assay" 13 : 31-33, 2018
• 12 Azad TD, "Therapeutic strategies to improve drug delivery across the blood-brain barrier" 38 (38): E9-, 2015
• 13 Cho K, "Therapeutic nanoparticles for drug delivery in cancer" 14 (14): 1310-1316, 2008
• 14 Wang G, "Theranostic hyaluronic acid–Iron Micellar nanoparticles for magnetic-field-enhanced in vivo Cancer chemotherapy" 13 (13): 78-86, 2018
• 15 Yhee JY, "Theranostic applications of organic nanoparticles for cancer treatment" 39 (39): 239-249, 2014
• 16 Liu Y, "The shape of things to come : importance of design in nanotechnology for drug delivery" 3 (3): 181-194, 2012
• 17 Leiro V, "The present and the future of degradable dendrimers and derivatives in theranostics" 26 (26): 1182-1197, 2015
• 18 Jevprasesphant R, "The influence of surface modification on the cytotoxicity of PAMAM dendrimers" 252 (252): 263-266, 2003
• 19 MacDonald IC, "The high splenic hematocrit : a rheological consequence of red cell flow through the reticular meshwork" 42 (42): 60-76, 1991
• 20 Albanese A, "The effect of nanoparticle size, shape, and surface chemistry on biological systems" 14 : 1-6, 2012
• 21 Svenson S, "The dendrimer paradox–high medical expectations but poor clinical translation" 44 (44): 4131-4144, 2015
• 22 Groothuis DR, "The blood-brain and blood-tumor barriers : a review of strategies for increasing drug delivery" 2 (2): 45-59, 2000
• 23 Fang J, "The EPR effect : unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect" 63 (63): 136-151, 2011
• 24 Gao H, "Targeted delivery of nano-therapeutics for major disorders of the central nervous system" 30 (30): 2485-2498, 2013
• 25 Teja AS, "Synthesis, properties, and applications of magnetic iron oxide nanoparticles" 55 (55): 22-45, 2009
• 26 Zhang Z, "Synthesis of pHresponsive starch nanoparticles grafted poly(l-glutamic acid)for insulin controlled release" 49 (49): 2082-2091, 2013
• 27 Liu C, "Synthesis of magnetic spinel ferrite CoFe2O4nanoparticles from ferric salt and characterization of the size-dependent superparamagnetic properties" 72 (72): 37-45, 2000
• 28 Nikitin A, "Synthesis of iron oxide nanorods for enhanced magnetic hyperthermia" 469 : 443-449, 2019
• 29 He M, "Synthesis of a chitosanbased photo-sensitive hydrogel and its biocompatibility and biodegradability" 166 : 228-235, 2017
• 30 Wong J, "Suspensions for intravenous(IV)injection : a review of development, preclinical and clinical aspects" 60 (60): 939-954, 2008
• 31 Schürch S, "Surfactant displaces particles toward the epithelium in airways and alveoli" 80 (80): 17-32, 1990
• 32 Maiti D, "Surface modified multifunctional ZnFe2O4nanoparticles for hydrophobic and hydrophilic anti-cancer drug molecule loading" 18 (18): 1439-1450, 2016
• 33 Sperling RA, "Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles" 368 (368): 1333-1383, 2010
• 34 Baek JS, "Surface modification of solid lipid nanoparticles for oral delivery of curcumin : Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake" 117 : 132-140, 2017
• 35 Weinstein JS, "Superparamagnetic iron oxide nanoparticles : diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review" 30 (30): 15-35, 2010
• 36 Capanema NS, "Superabsorbent crosslinkedcarboxymethyl cellulose-PEG hydrogels for potential wound dressing applications" 106 : 1218-1234, 2018
• 37 Athanasiou KA, "Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers" 17 (17): 93-102, 1996
• 38 Mishra V, "Solid lipid nanoparticles : emerging colloidal nano drug delivery systems" 10 (10): 191-, 2018
• 39 Tu Y, "Smart Pharmaceutical Nanocarriers" 83-116, 2016
• 40 Hooper JW, "Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge" 25 (25): 1814-1823, 2007
• 41 Alvarez-Román R, "Skin penetration and distribution of polymeric nanoparticles" 99 (99): 53-62, 2004
• 42 Siu KS, "SiRNA delivery methods" Humana Press 151-163, 2016
• 43 Kim JH, "Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy" 29 (29): 1920-1930, 2008
• 44 Lázaro IA, "Selective surface PEGylation of UiO-66 nanoparticles for enhanced stability, cell uptake, and pH-responsive drug delivery" 2 (2): 561-578, 2017
• 45 Wu C, "Redox-responsive supramolecular hydrogel based on 10-hydroxy camptothecin-peptide covalent conjugates with high loading capacity for drug delivery" 76 : 196-202, 2017
• 46 Qiao R, "Receptormediated delivery of magnetic nanoparticles across the blood–brain barrier" 6 (6): 3304-3310, 2012
• 47 Mignani S, "Recent therapeutic applications of the theranostic principle with dendrimers in oncology" 61 (61): 1367-1386, 2018
• 48 Lu H, "Recent progress on nanostructures for drug delivery applications" 2016 : 20-, 2016
• 49 Tan ML, "Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery" 31 (31): 184-193, 2010
• 50 Das S, "Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery" 12 (12): 62-76, 2011
• 51 Yuan ZX, "Randomly 50% Nacetylated low molecular weight chitosan as a novel renal targeting carrier" 15 (15): 269-278, 2007
• 52 Dey NS, "Quantum dot : Novel carrier for drug delivery" 2 : 448-458, 2011
• 53 Calvo P, "Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat" 15 (15): 1317-1326, 2002
• 54 Lu D, "Pulmonary vaccine delivery" 6 (6): 213-, 2007
• 55 Park CW, "Pulmonary inhalation aerosols for targeted antibiotics drug delivery" 16 (16): 32-36, 2011
• 56 Grotz E, "Pulmonary delivery of rifampicin-loaded soluplus micelles against Mycobacterium tuberculosis" 53 : 101170-, 2019
• 57 Mangal S, "Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers : challenges and opportunities" 38 (38): 782-, 2017
• 58 Xu C, "Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy" 295 : 153-163, 2019
• 59 Kaminskas LM, "Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy" 183 : 18-26, 2014
• 60 Ryan GM, "Pulmonary administration of PEGylatedpolylysinedendrimers : absorption from the lung versus retention within the lung is highly size-dependent" 10 (10): 2986-2995, 2013
• 61 Mohamed A, "Pulmonary Delivery of Nanocomposite Microparticles(NCMPs)incorporating miR-146a for Treatment of COPD" 569 : 118524-, 2019
• 62 Sahu A, "Prussian blue/serum albumin/indocyanine green as a multifunctional nanotheranostic agent for bimodal imaging guided laser mediated combinatorial phototherapy" 236 : 90-99, 2016
• 63 Zanganeh S, "Protein corona : opportunities and challenges" 75 : 143-147, 2016
• 64 Shoyele SA, "Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery" 314 (314): 1-8, 2006
• 65 Eivari HA, "Preparation of superparamagnetic iron oxide nanoparticles and investigation their magnetic properties" 1 (1): 10312-10313, 2012
• 66 Fan G, "Preparation of pomegranate Ellagic acid inclusion complex gel and its transdermal permeation in vitro" 174 : 724-731, 2017
• 67 Byron PR, "Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation" 75 (75): 433-438, 1986
• 68 Neubert RH, "Potentials of new nanocarriers for dermal and transdermal drug delivery" 77 (77): 1-2, 2011
• 69 Tosi G, "Potential use of polymeric nanoparticles for drug delivery across the bloodbrain barrier" 20 (20): 2212-2225, 2013
• 70 Liu Z, "Polysaccharides-based nanoparticles as drug delivery systems" 60 (60): 1650-1662, 2008
• 71 Farhat W, "Polysaccharides and lignin based hydrogels with potential pharmaceutical use as a drug delivery system produced by a reactive extrusion process" 104 : 564-575, 2017
• 72 Janes KA, "Polysaccharide colloidal particles as delivery systems for macromolecules" 47 (47): 83-97, 2001
• 73 Liu X, "Polymerization induced self-assembly of a site-specific interferon α-block copolymer conjugate into micelles with remarkably enhanced pharmacology" 140 (140): 10435-10438, 2018
• 74 Pridgen EM, "Polymeric nanoparticle technologies for oral drug delivery" 12 (12): 1605-1610, 2014
• 75 Allémann E, "Polymeric nano-and microparticles for the oral delivery of peptides and peptidomimetics" 34 (34): 171-189, 1998
• 76 Mitragotri S, "Physical approaches to biomaterial design" 8 (8): 15-23, 2009
• 77 Mathur V, "Physical and chemical penetration enhancers in transdermal drug delivery system" 4 (4): 173-, 2010
• 78 Gradishar WJ, "Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer" 23 (23): 7794-7803, 2005
• 79 Dias ML, "Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion(LDE)in patients with gynecologic cancers" 59 (59): 105-111, 2007
• 80 Parker SE, "Pharmacoeconomics of intravenous drug administration" 1 (1): 103-115, 1992
• 81 Loftsson T, "Pharmaceutical applications of cyclodextrins : basic science and product development" 62 (62): 1607-1621, 2010
• 82 Seki T, "Pharmaceutical Perspectives of Cancer Therapeutics" Springer 93-120, 2009
• 83 Baroli B, "Penetration of nanoparticles and nanomaterials in the skin: fiction or reality?" 99 (99): 21-50, 2010
• 84 Patel B, "Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia : toxicity data from the UKALL14 trial" 31 (31): 58-, 2017
• 85 Wei Y, "Passive lung-targeted drug delivery systems via intravenous administration" 19 (19): 129-136, 2014
• 86 De Jong WH, "Particle size-dependent organ distribution of gold nanoparticles after intravenous administration" 29 (29): 1912-1919, 2008
• 87 Champion JA, "Particle shape: a new design parameter for micro-and nanoscale drug delivery carriers" 121 (121): 3-9, 2007
• 88 Labieniec-Watala M, "PAMAM dendrimers : destined for success or doomed to fail? Plain and modified PAMAM dendrimers in the context of biomedical applications" 104 (104): 2-14, 2015
• 89 Ensign LM, "Oral drug delivery with polymeric nanoparticles : the gastrointestinal mucus barriers" 64 (64): 557-570, 2012
• 90 Kumar P, "Oral delivery of Methylthioadenosine to the brain employing solid lipid nanoparticles : pharmacokinetic, behavioral, and Histopathological evidences" 20 (20): 74-, 2019
• 91 Thanou M, "Ntrimethylated chitosan chloride(TMC)improves the intestinal permeation of the peptide drug buserelin in vitro(Caco-2 cells)and in vivo(rats)" 17 (17): 27-31, 2000
• 92 Shantha Kumar TR, "Novel delivery technologies for protein and peptide therapeutics" 7 (7): 261-276, 2006
• 93 Ismael GF, "Novel cytotoxic drugs : old challenges, new solutions" 34 (34): 81-91, 2008
• 94 Osman A, "Novel Levan and pNIPA temperature sensitive hydrogels for 5-ASA controlled release" 165 : 61-70, 2017
• 95 Mathaes R, "Non-spherical micro-and nanoparticles : fabrication, characterization and drug delivery applications" 12 (12): 481-492, 2015
• 96 Langer R, "New methods of drug delivery" 249 (249): 1527-1533, 1990
• 97 Menon GK, "New insights into skin structure: scratching the surface" 54 : S3-S17, 2002
• 98 Kreuter JO, "New adjuvants on a polymethylmethacrylate base" 13 (13): 204-210, 1976
• 99 Yang G, "Near-infrared-light responsive nanoscale drug delivery systems for cancer treatment" 320 : 100-117, 2016
• 100 Khanna P, "Nanotoxicity : an interplay of oxidative stress, inflammation and cell death" 5 (5): 1163-1180, 2015
• 101 Bamrungsap S, "Nanotechnology in therapeutics : a focus on nanoparticles as a drug delivery system" 7 (7): 1253-1271, 2012
• 102 Kumar S, "Nanotechnology as emerging tool for enhancing solubility of poorly water-soluble drugs" 2 (2): 227-250, 2012
• 103 Tarafdar JC, "Nanotechnology : Interdisciplinary science of applications" 12 (12): 219-226, 2013
• 104 Alyautdin R, "Nanoscale drug delivery systems and the blood–brain barrier" 9 : 795-811, 2014
• 105 Kreuter J, "Nanoparticulate systems for brain delivery of drugs" 47 (47): 65-81, 2001
• 106 Lademann J, "Nanoparticles–an efficient carrier for drug delivery into the hair follicles" 66 (66): 159-164, 2007
• 107 Mohanraj VJ, "Nanoparticles-a review" 5 (5): 561-573, 2006
• 108 Faraji AH, "Nanoparticles in cellular drug delivery" 17 (17): 2950-2962, 2009
• 109 Posadas I, "Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis" 11 (11): 833-849, 2016
• 110 Masserini M, "Nanoparticles for brain drug delivery" 2013 : 238428-, 2013
• 111 Wilczewska AZ, "Nanoparticles as drug delivery systems" 64 (64): 1020-1037, 2012
• 112 Prow TW, "Nanoparticles and microparticles for skin drug delivery" 63 (63): 470-491, 2011
• 113 Parveen S, "Nanoparticles : a boon to drug delivery, therapeutics, diagnostics and imaging" 8 (8): 147-166, 2012
• 114 Paranjpe M, "Nanoparticle-mediated pulmonary drug delivery : a review" 15 (15): 5852-5873, 2014
• 115 Singh R, "Nanoparticle-based targeted drug delivery" 86 (86): 215-223, 2009
• 116 Singh S, "Nanoparticle based drug delivery system : advantages and applications" 4 (4): 177-180, 2011
• 117 Wicki A, "Nanomedicine in cancer therapy : challenges, opportunities, and clinical applications" 200 : 138-157, 2015
• 118 Sasikumar A, "Nanomedicine for prostate cancer using nanoemulsion : a review" 260 : 111-123, 2017
• 119 Reis CP, "Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles" 2 (2): 8-21, 2006
• 120 Shakeel F, "Nanoemulsions as vehicles for transdermal delivery of aceclofenac" 8 (8): 191-, 2007
• 121 Khodabandehloo H, "Nanocarriers usage for drug delivery in cancer therapy" 9 (9): e3966-, 2016
• 122 Peer D, "Nanocarriers as an emerging platform for cancer therapy" 2 (2): 751-, 2007
• 123 Thakur K, "Nanocarrier for transdermal drug delivery systems" 5 : 708-723, 2016
• 124 Narvekar M, "Nanocarrier for poorly water-soluble anticancer drugs—barriers of translation and solutions" 15 (15): 822-833, 2014
• 125 Moghassemi S, "Nano-niosomes as nanoscale drug delivery systems : an illustrated review" 185 : 22-36, 2014
• 126 황승림, "Nano-enabled delivery systems across the blood–brain barrier" 대한약학회 37 (37): 24-30, 2014
• 127 Bencsik A, "Nano-and neurotoxicology : an emerging discipline" 160 : 45-63, 2017
• 128 Cherukula K, "Multifunctional inorganic nanoparticles : recent progress in thermal therapy and imaging" 6 (6): 76-, 2016
• 129 Yang HY, "Multifunctional and stimuli-responsive magnetic nanoparticle-based delivery Systems for Biomedical Applications" 1 (1): 1800011-, 2018
• 130 Sajomsang W, "Mucoadhesive property and biocompatibility of methylated N-aryl chitosan derivatives" 78 (78): 945-952, 2009
• 131 Weibel ER, "Morphometry of the human lung springer" 136-142, 1963
• 132 Kumar R, "Modified transdermal technologies : Breaking the barriers of drug permeation via the skin" 6 (6): 633-644, 2007
• 133 Chen Y, "Modern methods for delivery of drugs across the blood–brain barrier" 64 (64): 640-665, 2012
• 134 Hedley ML, "Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses" 4 (4): 365-368, 1998
• 135 Ito A, "Medical application of functionalized magnetic nanoparticles" 100 (100): 1-1, 2005
• 136 Arruebo M, "Magnetic nanoparticles for drug delivery" 2 (2): 22-32, 2007
• 137 Huang J, "Magnetic nanoparticle facilitated drug delivery for Cancer therapy with targeted and image-guided approaches" 26 (26): 3818-3836, 2016
• 138 Senyei A, "Magnetic guidance of drug-carrying microspheres" 49 (49): 3578-3583, 1978
• 139 Dai Z, "MMP2-sensitive PEG–lipid copolymers : a new type of tumor-targeted P-glycoprotein inhibitor" 8 (8): 12661-12673, 2016
• 140 Pandey H, "Liposome and their applications in cancer therapy" 59 : e16150477-, 2016
• 141 Yang J, "Lipid nanoparticles-encapsulated YF4 : a potential therapeutic Oral peptide delivery system for hypertension treatment" 10 : 102-, 2019
• 142 Morishita M, "Is the oral route possible for peptide and protein drug delivery?" 11 (11): 905-910, 2006
• 143 Agrawal U, "Is nanotechnology a boon for oral drug delivery?" 19 (19): 1530-1546, 2014
• 144 Nedyalkova M, "Iron oxide nanoparticles–in vivo/in vitro biomedical applications and in silico studies" 249 : 192-212, 2017
• 145 Silva GA, "Introduction to nanotechnology and its applications to medicine" 61 (61): 216-220, 2004
• 146 Park J, "Introduction of functionalized mesopores to metal–organic frameworks via metal–ligand–fragment coassembly" 134 (134): 20110-20116, 2012
• 147 Decuzzi P, "Intravascular delivery of particulate systems: does geometry really matter?" 26 (26): 235-, 2009
• 148 Dhuria SV, "Intranasal delivery to the central nervous system : mechanisms and experimental considerations" 99 (99): 1654-1673, 2010
• 149 Desai P, "Interaction of nanoparticles and cellpenetrating peptides with skin for transdermal drug delivery" 27 (27): 247-259, 2010
• 150 Gatti TH, "Insulin-loaded polymeric mucoadhesive nanoparticles : development, characterization and cytotoxicity evaluation" 54 : 1-10, 2018
• 151 Kalepu S, "Insoluble drug delivery strategies : review of recent advances and business prospects" 5 (5): 442-453, 2015
• 152 Núñez C, "Inorganic nanoparticles in diagnosis and treatment of breast cancer" 23 (23): 331-345, 2018
• 153 Patton JS, "Inhaling medicines : delivering drugs to the body through the lungs" 6 (6): 67-, 2007
• 154 El-Sherbiny IM, "Inhaled nano-and microparticles for drug delivery" 1 : 2-, 2015
• 155 Carvalho TC, "Influence of particle size on regional lung deposition–what evidence is there?" 406 (406): 1-10, 2011
• 156 Junyaprasert VB, "Influence of chemical penetration enhancers on skin permeability of ellagic acid-loaded niosomes" 8 (8): 110-117, 2013
• 157 Desai N, "Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albuminbound paclitaxel, ABI-007, compared with cremophor-based paclitaxel" 12 (12): 1317-1324, 2006
• 158 Eliezar J, "In vivo evaluation of folate decorated cross-linked micelles for the delivery of platinum anticancer drugs" 16 (16): 515-523, 2015
• 159 Xu R, "In vivo evaluation of a PAMAM-cystamine-(Gd-DO3A)conjugate as a biodegradable macromolecular MRI contrast agent" 232 (232): 1081-1089, 2007
• 160 Rodrigues LB, "In vitro release and characterization of chitosan films as dexamethasone carrier" 368 (368): 1-6, 2009
• 161 Treenate P, "In vitro drug release profiles of pH-sensitive hydroxyethylacryl chitosan/sodium alginate hydrogels using paracetamol as a soluble model drug" 99 : 71-78, 2017
• 162 Fortuna A, "In vitro and in vivo relevance of the Pglycoprotein probe substrates in drug discovery and development : focus on rhodamine 123, digoxin and talinolol" 1 : 1-23, 2011
• 163 Bruce JN, "Improving drug delivery to Intracerebral tumor and surrounding brain in a rodent model : a comparison of osmotic versus Bradykinin modification of the blood-brain and/or blood-tumor barriers" 43 (43): 889-, 1998
• 164 Vignaroli G, "Improvement of pyrazolo [3, 4-d] pyrimidines pharmacokinetic properties : nanosystem approaches for drug delivery" 6 : 21509-, 2016
• 165 Zhang Y, "IRAK1 and TRAF6, inversely modulated by antitumor miR-146a-5p, markedly promotes the progression of NSCLC" 10 (10): 4955-4968, 2017
• 166 El Fawal GF, "Hydroxyethyl cellulose hydrogel for wound dressing : fabrication, characterization and in vitro evaluation" 111 : 649-659, 2018
• 167 Lee H, "Hyaluronic acid− paclitaxel conjugate micelles : synthesis, characterization, and antitumor activity" 19 (19): 1319-1325, 2008
• 168 Huang G, "Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system" 278 : 122-126, 2018
• 169 Jose G, "Hyaluronic acid modified bubble-generating magnetic liposomes for targeted delivery of doxorubicin" 474 : 355-364, 2019
• 170 Li JF, "High-performance nanostructured thermoelectric materials" 2 (2): 152-158, 2010
• 171 Wu Y, "Gold nanoparticles in biological optical imaging" 2019
• 172 D’arrigo G, "Gellan gum nanohydrogel containing anti-inflammatory and anti-cancer drugs : a multidrug delivery system for a combination therapy in cancer treatment" 87 (87): 208-216, 2014
• 173 Siwowska K, "Folate receptorpositive gynecological cancer cells : In vitro and in vivo characterization" 10 (10): 72-, 2017
• 174 Ji X, "Fluorescent quantum dots : synthesis, biomedical optical imaging, and biosafety assessment" 124 : 132-139, 2014
• 175 Martincic M, "Filled carbon nanotubes in biomedical imaging and drug delivery" 12 (12): 563-581, 2015
• 176 Plapied L, "Fate of polymeric nanocarriers for oral drug delivery" 16 (16): 228-237, 2011
• 177 Khanmohammadi M, "Fabrication of single and bundled filament-like tissues using biodegradable hyaluronic acid-based hollow hydrogel fibers" 104 : 204-212, 2017
• 178 Lu M, "Fabrication of photocrosslinkable glycol chitosan hydrogel as a tissue adhesive" 181 : 668-674, 2018
• 179 Yin H, "Enhanced permeability and retention(EPR)effect based tumor targeting : the concept, application and prospect" 2 (2): 1010-, 2014
• 180 Huang Z, "Endotracheal Aerosolization device for laboratory investigation of pulmonary delivery of nanoparticle suspensions : in vitro and in vivo validation" 15 (15): 5521-5533, 2018
• 181 Barichello JM, "Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method" 25 (25): 471-476, 1999
• 182 Mekuria SL, "Encapsulation of gadolinium oxide nanoparticle(Gd2O3)contrasting agents in PAMAM dendrimer templates for enhanced magnetic resonance imaging in vivo" 9 (9): 6782-6795, 2017
• 183 Bramson J, "Enabling topical immunization via microporation : a novel method for pain-free and needle-free delivery of adenovirus-based vaccines" 10 (10): 251-, 2003
• 184 Kraft JC, "Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems" 103 (103): 29-52, 2014
• 185 Béduer A, "Elucidation of the role of carbon nanotube patterns on the development of cultured neuronal cells" 28 (28): 17363-17371, 2012
• 186 Cooke M, "Efficacy and tolerability of accelerated-dose low-molecular-weight iron dextran(Cosmofer)in patients with chronic kidney disease" 35 (35): 69-74, 2012
• 187 Blade J, "Efficacy and safety of pegylated liposomal doxorubicin in combination with bortezomib for multiple myeloma : effects of adverse prognostic factors on outcome" 11 : 44-49, 2011
• 188 Harris JM, "Effect of pegylation on pharmaceuticals" 2 (2): 214-, 2003
• 189 Anilkumar TS, "Dual targeted magnetic photosensitive liposomes for photothermal/photodynamic tumor therapy" 473 : 241-252, 2019
• 190 Dilnawaz F, "Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy" 31 (31): 3694-3706, 2010
• 191 LiCalsi C, "Dry powder inhalation as a potential delivery method for vaccines" 17 (17): 1796-1803, 1999
• 192 El-Bachá RD, "Drug metabolizing enzymes in cerebrovascular endothelial cells afford a metabolic protection to the brain" 45 (45): 15-23, 1999
• 193 Matuszak J, "Drug delivery to atherosclerotic plaques using superparamagnetic iron oxide nanoparticles" 13 : 8443-, 2018
• 194 Redhead HM, "Drug delivery in poly(lactide-co-glycolide)nanoparticles surface modified with poloxamer 407 and poloxamine 908 : in vitro characterisation and in vivo evaluation" 70 (70): 353-363, 2001
• 195 Hörmann K, "Drug delivery and drug targeting with parenteral lipid nanoemulsions—a review" 223 : 85-98, 2016
• 196 Barenholz Y, "Doxil(R)--the first FDA-approved nano-drug : lessons learned" 160 : 117-134, 2012
• 197 Charlton S, "Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device" 30 (30): 295-302, 2007
• 198 Nakamura H, "Direct permeation of nanoparticles across cell membrane : a review" 35 : 49-65, 2018
• 199 Lee H, "Device-assisted transdermal drug delivery" 127 : 35-45, 2017
• 200 Elhissi AM, "Development and characterisation of freeze-dried liposomes containing two anti-asthma drugs" 5 (5): 184-188, 2010
• 201 Kim Y, "Determination of nanomolar levels of reactive oxygen species in microorganisms and aquatic environments using a single nanoparticle-based optical sensor" 967 : 85-92, 2017
• 202 Zrazhevskiy P, "Designing multifunctional quantum dots for bioimaging, detection, and drug delivery" 39 (39): 4326-4354, 2010
• 203 Tian Y, "Designing micellar nanocarriers with improved drug loading and stability based on solubility parameter" 12 (12): 816-825, 2015
• 204 Makhlof A, "Design and evaluation of novel pHsensitive chitosan nanoparticles for oral insulin delivery" 42 (42): 445-451, 2011
• 205 Brown MB, "Dermal and transdermal drug delivery systems : current and future prospects" 13 (13): 175-187, 2006
• 206 Münch S, "Dermal and transdermal delivery of pharmaceutically relevant macromolecules" 119 : 235-242, 2017
• 207 Palmerston Mendes L, "Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy" 22 (22): 1401-, 2017
• 208 Tripathy S, "Dendrimers and their applications as novel drug delivery carriers" 3 (3): 142-149, 2013
• 209 Qiao Z, "Dendrimer-based molecular imaging contrast agents" 44 : 1-27, 2015
• 210 Jain K, "Dendrimer toxicity: Let's meet the challenge" 394 (394): 122-142, 2010
• 211 Jędrzak A, "Dendrimer based theranostic nanostructures for combined chemo-and photothermal therapy of liver cancer cells in vitro" 173 : 698-708, 2019
• 212 Lu CT, "Current approaches to enhance CNS delivery of drugs across the brain barriers" 9 : 2241-2257, 2014
• 213 Lü JM, "Current advances in research and clinical applications of PLGA-based nanotechnology" 9 (9): 325-341, 2009
• 214 Pai AB, "Complexity of intravenous iron nanoparticle formulations : implications for bioequivalence evaluation" 1407 (1407): 17-25, 2017
• 215 Patel MP, "Chitosan mediated targeted drug delivery system : a review" 13 (13): 536-557, 2010
• 216 Raftery R, "Chitosan for gene delivery and orthopedic tissue engineering applications" 18 (18): 5611-5647, 2013
• 217 Tozaki H, "Chitosan capsules for colon-specific drug delivery : enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats" 82 (82): 51-61, 2002
• 218 M Ways T, "Chitosan and its derivatives for application in mucoadhesive drug delivery systems" 10 (10): 267-, 2018
• 219 Raavé R, "Chemotherapeutic drug delivery by tumoral extracellular matrix targeting" 274 : 1-8, 2018
• 220 Xue M, "Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles" 8 : 4677-, 2013
• 221 Barua S, "Challenges associated with penetration of nanoparticles across cell and tissue barriers : a review of current status and future prospects" 9 (9): 223-243, 2014
• 222 Muller RH, "Challenges and solutions for the delivery of biotech drugs–a review of drug nanocrystal technology and lipid nanoparticles" 113 (113): 151-170, 2004
• 223 Yu S, "Carboxyl group(−CO2H)functionalized ferrimagnetic iron oxide nanoparticles for potential bio-applications" 14 (14): 2781-2786, 2004
• 224 Lim SY, "Carbon quantum dots and their applications" 44 (44): 362-381, 2015
• 225 Karimi M, "Carbon nanotubes part II : a remarkable carrier for drug and gene delivery" 12 (12): 1089-1105, 2015
• 226 Fabbro A, "Carbon nanotubes in neuroregeneration and repair" 65 (65): 2034-2044, 2013
• 227 Son KH, "Carbon nanotubes as cancer therapeutic carriers and mediators" 11 : 5163-, 2016
• 228 Kushwaha SK, "Carbon nanotubes as a novel drug delivery system for anticancer therapy : a review" 49 (49): 629-643, 2013
• 229 Keefer EW, "Carbon nanotube coating improves neuronal recordings" 3 (3): 434-, 2008
• 230 Wei X, "Brain tumor-targeted drug delivery strategies" 4 (4): 193-201, 2014
• 231 Bicker J, "Blood–brain barrier models and their relevance for a successful development of CNS drug delivery systems : a review" 87 (87): 409-432, 2014
• 232 Okon E, "Biodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study" 71 (71): 895-903, 1994
• 233 Kumari A, "Biodegradable polymeric nanoparticles based drug delivery systems" 75 (75): 1-8, 2010
• 234 Soppimath KS, "Biodegradable polymeric nanoparticles as drug delivery devices" 70 (70): 1-20, 2001
• 235 Badri W, "Biodegradable polymer based nanoparticles : dermal and transdermal drug delivery" 3 (3): 141-149, 2014
• 236 Panyam J, "Biodegradable nanoparticles for drug and gene delivery to cells and tissue" 55 (55): 329-347, 2003
• 237 Islam MS, "Bioadhesive Food-Protein Nanoparticles as Pediatric Oral Drug Delivery system" 11 : 18062-18073, 2019
• 238 Ma M, "Au capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo−/chemo-therapy and multimodal imaging" 33 (33): 989-998, 2012
• 239 Abbott NJ, "Astrocyte–endothelial interactions at the blood–brain barrier" 7 (7): 41-53, 2006
• 240 Pankhurst QA, "Applications of magnetic nanoparticles in biomedicine" 36 (36): R167-, 2003
• 241 Kim T, "Applications of inorganic nanoparticles as therapeutic agents" 25 (25): 012001-, 2013
• 242 Uchechi O, "Application of Nanotechnology in Drug Delivery" InTech C 193-235, 2014
• 243 Seungbin Cha, "Antibody-mediated oral delivery of therapeutic DNA for type 2 diabetes mellitus" 한국생체재료학회 22 (22): 183-194, 2018
• 244 Alyautdin R, "Analgesic activity of the hexapeptidedalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate)nanoparticles" 41 (41): 44-48, 1995
• 245 Mohammed M, "An overview of chitosan nanoparticles and its application in non-parenteral drug delivery" 9 (9): 53-, 2017
• 246 Chen R, "Aloe-emodin loaded solid lipid nanoparticles : formulation design and in vitro anti-cancer study" 22 (22): 666-674, 2015
• 247 Cardoso VF, "Advances in magnetic nanoparticles for biomedical applications" 7 (7): 1700845-, 2018
• 248 Yhee JY, "Advanced therapeutic strategies for chronic lung disease using nanoparticle-based drug delivery" 5 (5): 82-, 2016
• 249 Yoo JW, "Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery" 63 (63): 1247-1256, 2011
• 250 Shi C, "Active-targeting docetaxel-loaded mixed micelles for enhancing antitumor efficacy" 264 : 172-178, 2018
• 251 Andonova V, "Acrylic Polymers in Healthcare" Intech Open 101-125, 2017
• 252 Waite CL, "Acetylation of PAMAM dendrimers for cellular delivery of siRNA" 9 (9): 38-, 2009
• 253 Hoesel LM, "Ability of antioxidant liposomes to prevent acute and progressive pulmonary injury" 10 (10): 963-972, 2008
• 254 Nassimi M, "A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung" 75 (75): 107-116, 2010
• 255 Steichen SD, "A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics" 48 (48): 416-427, 2013
• 256 Muzzalupo R, "A new approach for the evaluation of niosomes as effective transdermal drug delivery systems" 79 (79): 28-35, 2011
• 257 Bhadra D, "A PEGylated dendritic nanoparticulate carrier of fluorouracil" 257 (257): 111-124, 2003